Seeking Alpha

Pfizer's (PFE -0.9%) Lyrica nerve-pain drug didn't hurt reproductive function in healthy males...

Pfizer's (PFE -0.9%) Lyrica nerve-pain drug didn't hurt reproductive function in healthy males in an FDA post-approval trial. Meanwhile, in a test for EU regulators of the medicine for treating generalized anxiety disorder, patients showed a low rate of symptoms as they tapered off from the drug after 3 and 6 months.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs